Allstate Corporation The Common Stock(ALL)

Trading Analysis Report: ALL

• Analysis date: 2026-05-31
• Processed decision: Overweight
• Price Target: $244.00

I. Analyst Team Reports

Market Analyst

Market Analyst Report

Allstate closed at $206.09 on May 29, 2026, with a post-market snapshot near $206.39. Unlike the more speculative names in the queue, ALL is a large-cap insurer with low beta, strong cash generation, and a Q1 2026 underwriting rebound that supports a constructive stance.

Investment Snapshot

The market setup supports Overweight. ALL has strong underwriting momentum, low valuation multiples, capital return, and a target gap versus the analyst median.

Sentiment Analyst

Sentiment Analyst Report

Sentiment around Allstate is constructive but not euphoric. The StockNote queue ranks ALL at #31, mention rank #47, with 10 mentions and 42 upvotes. That is meaningful enough to show investor attention, but not a meme-style crowding signal.

The bullish narrative is straightforward: Allstate's Q1 2026 results showed a major underwriting inflection. Property-Liability combined ratio improved to 82.0, underlying combined ratio improved to 80.3, catastrophe losses fell sharply, and adjusted net income rose to $2.797 billion.

Sentiment also benefits from capital return. The company repurchased $614 million of treasury stock in Q1, paid $261 million of common dividends, and launched a new $4 billion repurchase authorization according to the Q1 materials.

The bearish narrative is that insurance results can reverse if catastrophe losses normalize higher or prior-year reserve releases fade. The Q1 headline profit was helped by lower catastrophe losses and reserve benefits, so investors should not annualize every dollar of the quarter.

Sentiment conclusion: positive but disciplined. ALL is not priced for perfection, so the sentiment risk/reward is favorable.

News Analyst

News Analyst Report

Allstate reported Q1 2026 total revenues of $16.941 billion, up 3.0% from $16.452 billion a year earlier. Net income applicable to common shareholders was $2.428 billion, or $9.25 diluted EPS, versus $566 million, or $2.11 diluted EPS, in Q1 2025.

Adjusted net income was $2.797 billion, or $10.65 per diluted share. Net investment income increased to $938 million, up 9.8% year over year.

The main driver was Property-Liability underwriting. Premiums earned increased 5.5% to $14.802 billion, premiums written increased 2.3% to $14.625 billion, underwriting income increased to $2.658 billion, and the combined ratio improved to 82.0 from 97.4. The underlying combined ratio improved to 80.3 from 83.1.

Catastrophe losses fell to $1.240 billion from $2.202 billion. Policies in force increased 2.3% to 38.576 million in Property-Liability and total policies in force increased 2.5% to 212.052 million.

The 10-Q also showed book value per common share of $113.52, up 52.2% year over year. Allstate shareholders' equity was $31.607 billion, debt was $7.491 billion, and operating cash flow was $3.562 billion in Q1.

News conclusion: Q1 was a high-quality beat because it combined underwriting profitability, policy growth, investment income, book value growth, and capital return.

Fundamentals Analyst

Fundamentals Analyst Report

Allstate's fundamentals are strong. The company is generating underwriting income and investment income at the same time, which is the desired earnings mix for a property-casualty insurer. The Q1 Property-Liability combined ratio of 82.0 leaves a large profitability buffer even if catastrophes rise later in the year.

The valuation is attractive relative to earnings. The local snapshot shows trailing P/E of 4.56x, forward P/E of 7.84x, P/S of 0.78x, and P/B of 1.80x. For a company producing TTM net income above $12 billion and low beta, those multiples look undemanding.

Book value is improving. The 10-Q showed Allstate common shareholders' equity of $31.607 billion, and the earnings release showed book value per common share of $113.52, up 52.2% year over year. Capital return is also material through dividends and buybacks.

The risks are insurance-specific. Catastrophe losses can spike, reserve development can reverse, pricing competition can pressure growth, and investment losses can affect GAAP income. Q1 also benefited from lower catastrophe losses and prior-year reserve releases, so normalized earnings should be lower than simply annualizing Q1.

Fundamental conclusion: even after normalizing the unusually strong quarter, ALL trades below a fair value range implied by earnings, book value growth, and capital return. Overweight is appropriate.

II. Research Team Decision

Bull Researcher

Bull Researcher View

The bull case is that Allstate has moved from repair mode to profitable growth. The combined ratio of 82.0 and underlying combined ratio of 80.3 show that pricing and underwriting actions are working.

Policy growth adds credibility. Total policies in force grew 2.5%, Property-Liability policies grew 2.3%, and management is expanding affordable auto and homeowners products across more states. This is not only margin recovery; it is margin recovery with unit growth.

Capital return is meaningful. With strong operating cash flow, a dividend yield around 2.1%, and a new $4B buyback authorization, shareholders can benefit even if the multiple only partially rerates.

Bull conclusion: ALL deserves a higher multiple because earnings quality and growth are improving while the stock remains near the 200-day average.

Bear Researcher

Bear Researcher View

The bear case is that Q1 was unusually favorable. Catastrophe losses fell by almost $1 billion year over year, and reserve releases helped the reported combined ratio. If catastrophe activity normalizes upward, earnings can fall quickly.

Insurance is cyclical and competitive. Premium affordability efforts can slow written premium growth, while competitors may respond aggressively as industry margins recover. Auto repair costs, litigation, weather severity, and reinsurance costs remain variables.

The stock is not distressed. P/B is around 1.8x, and the target case relies on sustained underwriting performance rather than one quarter. If investors view Q1 as peak profitability, the multiple may stay low.

Bear conclusion: ALL is a good insurer, but the market may discount Q1 because of catastrophe and reserve variability.

Research Manager

Research Manager Decision

The research team recommends Overweight for Allstate with a $244.00 price target.

Price Target: $244.00

The $244 target rounds the captured analyst median target of $243.50. That anchor is appropriate because the latest close of $206.09 offers roughly high-teens upside while the company's Q1 underwriting, investment income, book value, and capital return all support a constructive view.

The decision rests on four points:

1. Q1 2026 underwriting profitability improved sharply, with an 82.0 combined ratio.
2. Underlying combined ratio improved, suggesting the result was not only catastrophe timing.
3. Valuation remains low at under 8x forward earnings and below 2x book.
4. Capital return through dividends and buybacks supports per-share value.

Portfolio implication: accumulate or hold ALL for a 6-12 month rerating toward $244, while monitoring catastrophe losses and reserve development.

III. Trading Team Plan

Trader

Trader Investment Plan

Recommendation: Overweight

Price Target: $244.00

Time horizon: 6-12 months.

Entry framework: ALL is trading near the 200-day average and below the 50-day average after strong Q1 results. That creates a reasonable entry zone for investors who want insurance exposure with earnings momentum.

Position sizing: Use normal large-cap financials sizing. The low beta supports core exposure, but catastrophe risk means the position should not be oversized.

Upside triggers:

• Combined ratio remains near or below the low-80s.
• Policy growth continues while affordability actions protect retention.
• Investment income keeps rising.
• Buybacks reduce share count while book value grows.

Downside triggers:

• Catastrophe losses spike above expectations.
• Prior-year reserve development turns unfavorable.
• New business growth pressures margins.
• The stock breaks below the 52-week low near $188.

Risk control: Reassess if ALL trades below $188 without evidence that underwriting margins remain intact, or if catastrophe losses erode the Q1 profitability thesis.

IV. Risk Management Team Decision

Aggressive Analyst

Aggressive Risk Analyst

The aggressive view supports adding. ALL has a rare combination of low valuation, strong current earnings, improved underwriting, and a capital return program. A move to the analyst median target does not require an extreme multiple.

The stock's low beta also makes it attractive as a defensive financials position during broader market volatility. If the market starts paying for normalized underwriting improvement, the rerating can be steady.

Aggressive conclusion: Overweight is justified, with room to add on weakness near the 200-day average.

Conservative Analyst

Conservative Risk Analyst

The conservative view is constructive but risk-aware. Insurance earnings can be volatile, and catastrophe losses can undo a strong quarter quickly. Prior-year reserve releases should not be treated as permanent earnings power.

Still, the current valuation provides a margin of safety. Forward P/E below 8x, P/B below 2x, and strong cash generation leave room for conservative investors to hold the stock.

Conservative conclusion: Overweight is acceptable, but position sizing should respect weather and reserve risk.

Neutral Analyst

Neutral Risk Analyst

The neutral view sees Allstate as a quality rerating candidate. The stock has not performed over one year despite earnings and book value improvement, which creates a setup for catch-up performance.

The $244 target is balanced because it does not assume the highest analyst target or a heroic multiple. It simply moves the stock toward the current median view after a strong operating quarter.

Neutral conclusion: Overweight with monitoring of catastrophe losses and combined ratio trends.

V. Portfolio Manager Decision

Portfolio Manager

Portfolio Manager Decision

Final decision: Overweight

Price Target: $244.00

Allstate delivered a strong Q1 2026. Revenue grew, adjusted net income was $2.797 billion, combined ratio improved to 82.0, underlying combined ratio improved to 80.3, book value per share rose sharply, and the company continued returning capital.

The valuation remains attractive. At $206.09, ALL trades below the captured analyst median target, below 8x forward earnings, around 1.8x book, and near its 200-day average. That is a favorable setup for a large-cap insurer with improved underwriting performance.

For StockNote publication, the actionable stance is: Overweight ALL with a $244.00 target; buy the underwriting recovery and capital return, while monitoring catastrophe and reserve-development volatility.